logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

In the past week, IBIT saw the highest fund inflows, ranking first on BlackRock's ETF list, with ETHA coming in fifth.
Trump Seeks to Impose Tariffs of at Least 15-20% on All EU Goods

You may also like

Share
copy

Gainers

Latest Crypto News

11:45

WSJ: Investors are Wary of a New Round of the "Crypto Winter"

11:45

Aethir Releases 12-Month Future Roadmap to Accelerate Growth in Global Enterprise AI Computing Business

11:15

24-hour Spot Funding Inflow/Outflow List: ETH Net Outflow of $126 million, ZEC Net Outflow of $18.2 million

11:15

Bloomberg: Fed Never So Split on Long Rate Strategy

10:45

Key Transaction Data: US 10-Year Treasury Yield Rises to 4.086%

Read more
Community
icon
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MM[email protected]

VIP Services[email protected]